Thrombolysis With Intravenous Tissue Plasminogen Activator Predicts a Favorable Discharge Disposition in Patients With Acute Ischemic Stroke
- 1 March 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 42 (3), 700-704
- https://doi.org/10.1161/strokeaha.110.604108
Abstract
Acute ischemic stroke patients who receive recombinant tissue plasminogen activator (rt-PA) within 3 hours of symptom onset are 30% more likely to have minimal to no disability at 3 months. During hospitalization, short-term disability is subjectively measured by discharge disposition, whether to home, inpatient rehabilitation, a skilled nursing facility, or subacute care. There are no studies assessing the role of recombinant tissue plasminogen activator use as a predictor of poststroke discharge disposition. We conducted a retrospective analysis of all patients with ischemic stroke who presented within the original three hour window for intravenous thrombolysis, and who were admitted to the University of Texas Houston Medical School Stroke Service at Memorial Hermann Hospital - Texas Medical Center between January 2004 and October 2009. Baseline demographics and National Institute of Health Stroke Scale score were collected. Cerebrovascular disease risk factors were used for risk stratification in the multivariate regression. Out of 2225 patients with acute ischemic stroke, 1019 were discharged to home, 719 to inpatient rehabilitation, 371 to a skilled nursing facility and 116 to subacute care. Patients who received recombinant tissue plasminogen activator therapy were more likely to be discharged home compared to the other levels of care ( P P = 0.123); Skilled Nursing Facility versus Subacute Care ( P = 0.605). Patients who receive intravenous recombinant tissue plasminogen activator as treatment for acute ischemic stroke are more likely to be discharged directly home after hospitalization. This study is limited by its retrospective nature and the undetermined role of psychosocial factors related to discharge.This publication has 14 references indexed in Scilit:
- Stroke: Working toward a Prioritized World AgendaCerebrovascular Diseases, 2010
- Medicare program; prospective payment system and consolidated billing for skilled nursing facilities for FY 2010; minimum data set, version 3.0 for skilled nursing facilities and Medicaid nursing facilities. Final rule.2009
- Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2010. Final rule.2009
- Principles of Experience-Dependent Neural Plasticity: Implications for Rehabilitation After Brain DamageJournal of Speech, Language, and Hearing Research, 2008
- What is intermediate care?BMJ, 2004
- Characteristics of the National Institute of Health Stroke Scale: Results from a Population-Based Stroke Cohort at Baseline and after One YearCerebrovascular Diseases, 2003
- The Contribution of Insurance Coverage and Community Resources to Reducing Racial/Ethnic Disparities in Access to CareHealth Services Research, 2003
- Lifetime Cost of Stroke in the United StatesStroke, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeThe New England Journal of Medicine, 1995
- A Population-Based Assessment of the Impact and Burden of Caregiving for Long-term Stroke SurvivorsStroke, 1995